Prevalence and correlates of renal disease in older lithium users: A population-based study

American Journal of Geriatric Psychiatry

Volumn 22, Issue 11, 2014, Pages 1075-1082

  Rej, Soham ^a   Shulman, Kenneth ^b   Herrmann, Nathan ^b   Harel, Ziv ^c   Fischer, Hadas D ^e   Fung, Kinwah ^e,f   Gruneir, Andrea ^d,e,f  

^a MCGILL UNIVERSITY   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^f WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

acute kidney disease; chronic kidney disease; drug safety; geriatric; Lithium; nephrogenic diabetes insipidus

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HYDROCHLOROTHIAZIDE; LITHIUM; LOOP DIURETIC AGENT; LITHIUM DERIVATIVE; PSYCHOTROPIC AGENT;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CANADA; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; ICD-10; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROGENIC DIABETES INSIPIDUS; PREVALENCE; PSYCHIATRIST; VERY ELDERLY; ACUTE KIDNEY INJURY; CHEMICALLY INDUCED; DIABETES INSIPIDUS, NEPHROGENIC; KIDNEY DISEASES; MOOD DISORDERS; RENAL INSUFFICIENCY, CHRONIC;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES INSIPIDUS, NEPHROGENIC; FEMALE; HUMANS; KIDNEY DISEASES; LITHIUM COMPOUNDS; MALE; MOOD DISORDERS; ONTARIO; PREVALENCE; PSYCHOTROPIC DRUGS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84927969937     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2014.01.015     Document Type: Article

References (36)

1. Maust DT, Oslin DW, Thase ME: Going beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: A critical review. Am J Geriatr Psychiatry 2013; 21: 973-986
2. Goodwin FK, Fireman B, Simon GE, et al: Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003; 290:1467-1473
3. Geddes JR, Goodwin GM, Rendell J, et al: Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. Lancet 2010; 375:385-395
4. Baldessarini RJ, Tondo L, Hennen J: Lithium treatment and suicide risk in major affective disorders: Update and new findings. J Clin Psychiatry 2003; 64(suppl 5):44-52
5. Shulman KI, Rochon P, Sykora K, et al: Changing prescription patterns for lithium and valproic acid in old age: Shifting practice without evidence. BMJ 2003; 326:960-961
6. Al Jurdi RK, Marangell LB, Petersen NJ, et al: Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a "recovered" status in the systematic treatment enhancement program for bipolar disorder. Am J Geriatr Psychiatry 2008; 16:922-933
7. Rej S, Herrmann N, Shulman K: The effects of lithium on renal function in older adults-A systematic review. J Geriatr Psychiatry Neurol 2012; 25:51-61
8. Hendrie HC, Lindgren D, Hay DP, et al: Comorbidity profile and healthcare utilization in elderly patients with serious mental illnesses. Am J Geriatr Psychiatry 2013; 21:1267-1276
9. McKnight RF, Adida M, Budge K, et al: Lithium toxicity profile: A systematic review and meta-analysis. Lancet 2012; 379: 721-728
10. Fahy S, Lawlor BA: Discontinuation of lithium augmentation in an elderly cohort. Int J Geriatr Psychiatry 2001; 16:1004-1009
11. Wells JE, Cross NB, Richardson AK: Toxicity profile of lithium. Lancet 2012; 379:2338
12. Bendz H, Schon S, Attman PO, et al: Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 2010; 77: 219-224
13. Weinstein JR, Anderson S: The aging kidney: Physiological changes. Adv Chronic Kidney Dis 2010; 17:302-307
14. Juurlink DN, Mamdani MM, Kopp A, et al: Drug-induced lithium toxicity in the elderly: A population-based study. J Am Geriatr Soc 2004; 52:794-798
15. Waller DG, Edwards JG, Polak A: Neuroleptics, lithium and renal function. Br J Psychiatry 1985; 146:510-514
16. Nora RM, Hariprasad MK, Beke AZ: Urinary osmolality in lithium and non-lithium treated psychiatric patients. J Clin Psychiatry 1981; 42:254
17. Canadian Institute for Health Information: NACRS Background and General Data Limitations Documentation 2006-2007. Available at: Http://www.cihi.ca/CIHI-ext-portal/pdf/internet/NACRS-exec-summ-2006-2007-EN. 2007
18. Van Melick EJ, Meinders AE, Hoffman TO, et al: Renal effects of long-term lithium therapy in the elderly: A cross-sectional study. Int J Geriatr Psychiatry 2008; 23:685-692
19. Wald R, Quinn RR, Adhikari NK, et al: Risk of chronic dialysis and death following acute kidney injury. Am J Med 2012; 125: 585-593
20. Hwang YJ, Shariff SZ, Gandhi S, et al: Validity of the International Classification of Diseases, Tenth Revision code for acute kidney injury in elderly patients at presentation to the emergency department and at hospital admission. BMJ Open 2012; 2(6); pii: E001821. doi: 10.1136/bmjopen-2012-001821
21. Fleet JL, Dixon SN, Shariff SZ, et al: Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol 2013; 14:81
22. Rej S, Senouci SI, Looper K, et al: Using hypernatraemic events to predict reduced renal function in elderly lithium patients: A brief report. Psychogeriatrics 2013; 13:25-28
23. Crowe E, Halpin D, Stevens P: Early identification and management of chronic kidney disease: Summary of NICE guidance. BMJ 2008; 337:a1530
24. Coresh J, Selvin E, Stevens LA, et al: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047
25. Stevens LA, Fares G, Fleming J, et al: Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: Evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol 2005; 16:2439-2448
26. Boton R, Gaviria M, Batlle DC: Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 1987; 10:329-345
27. Rej S, Abitbol R, Looper K, et al: Chronic renal failure in lithiumusing geriatric patients: Effects of lithium continuation versus discontinuation-A 60-month retrospective study. Int J Geriatr Psychiatry 2013; 28:450-453
28. Hardy BG, Shulman KI, Zucchero C: Gradual discontinuation of lithium augmentation in elderly patients with unipolar depression. J Clin Psychopharmacol 1997; 17:22-26
29. Bendz H, Aurell M, Balldin J, et al: Kidney damage in long-term lithium patients: A cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant 1994; 9: 1250-1254
30. Walker RJ, Leader JP, Bedford JJ, et al: Chronic interstitial fibrosis in the rat kidney induced by long-term (6-mo) exposure to lithium. Am J Physiol Renal Physiol 2013; 304:F300eF307
31. Rej S, Looper K, Segal M: The effect of serum lithium levels on renal function in geriatric outpatients: A retrospective longitudinal study. Drugs Aging 2013; 30:409-415
32. Head L, Dening T: Lithium in the over-65s: Who is taking it and who is monitoring it? A survey of older adults on lithium in the Cambridge Mental Health Services catchment area. Int J Geriatr Psychiatry 1998; 13:164-171
33. Lepkifker E, Sverdlik A, Iancu I, et al: Renal insufficiency in longterm lithium treatment. J Clin Psychiatry 2004; 65:850-856
34. Rej S, Looper K, Segal M: Do antidepressants lower the prevalence of lithium-associated hypernatremia in the elderly? A retrospective study. Canadian Geriatr J 2013; 16:38-42
35. Ng F, Mammen OK, Wilting I, et al: The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord 2009; 11:559-595
36. Sproule BA, Hardy BG, Shulman KI: Differential pharmacokinetics of lithium in elderly patients. Drugs Aging 2000; 16:165-177